However, we can see from the results of the analysis that CLR expression has a tight and highly consistent positive correlation with a wide range of almost all of the crucial immune-checkpoint molecules, which suggests that high levels of expression of CLRs are linked with a highly immunosuppressive tumor microenvironment in bladder cancer. The gene discussed is LARS1; the disease is urinary bladder cancer.